RecruitingPhase 1NCT06846749

Slow Introduction of Nutrition for Ill Malnourished Children

Reduced Calorie Feeds in the Early Management of Ill Severely Malnourished Children: a Phase I Clinical Trial


Sponsor

The Hospital for Sick Children

Enrollment

135 participants

Start Date

Feb 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if giving lower calorie feeds during the first stage of treatment helps improve survival in severely malnourished children who are ill. The main question it aims to answer is: Is it safe to feed ill severely malnourished children lower calorie feeds during the early treatment phase? Researchers will compare two lower calorie feeds (F50 and F35) to the standard feed (F75) to see if they help children recover safely without increasing their risk of low blood sugar (hypoglycemia). Participants will: * Receive one of the lower calorie feeds (F50 or F35) or the standard feed (F75) during their hospital stay. * Be closely monitored for low blood sugar and signs for worsening of clinical symptoms. * Be treated until they are stable and ready to be fed more calories to help them gain weight.


Eligibility

Min Age: 6 MonthsMax Age: 59 Months

Inclusion Criteria6

  • Age - greater than or equal to 6 months to less than 59 months (age range for which WHO guidelines were developed and where children are not expected to be exclusively breastfeeding
  • Admitted to hospital with acute, non-traumatic illness and having received a maximum of 2 feeds of F75 at time of enrolment
  • Severe malnutrition (WHZ \<-3 z-scores of the median WHO growth standards and/or MUAC \<115mm)
  • Accompanied by care provider able to provide written or witnessed informed consent
  • Primary caregiver plans to stay in the study area for the duration of the study
  • Having no more than one clinical sign displayed below "Clinical/Lab Feature \& Criteria"

Exclusion Criteria20

  • Has oedematous malnutrition (excluded for this safety focused trial as fluid accumulation influences weight which is used to calculate required caloric intake)
  • Requires immediate cardiac/respiratory resuscitation (chest compressions/ventilation)
  • Clinical contraindications for enteral nutrition
  • Admission for traumatic or surgical indication
  • Weighs \<3.5kg
  • Presence of terminal illness likely to result in death within 6 months
  • Known congenital heart disease
  • Have had 2 documented hypoglycaemic events in hospital
  • More than one clinical sign displayed below "Clinical/Lab Feature \& Criteria"
  • Primary caregiver declines to provide informed consent
  • Clinical/Lab Feature \& Criteria Guidelines
  • Clinical/Lab Feature: Respiratory distress Oxygenation Criteria: "Subcostal in-drawing" or "nasal flaring" or "head-nodding"
  • Clinical/Lab Feature: Oxygenation Criteria: "Central cyanosis" or SaO2 \<90%
  • Clinical/Lab Feature: Circulation Criteria: Limb temperature gradient or capillary refill \>3 seconds
  • Clinical/Lab Feature: Reduced conscious level Criteria: AVPU \< "A"
  • Clinical/Lab Feature: Rapid pulse Criteria: Heartbeat per min \> 180
  • Clinical/Lab Feature: Severe anemia Criteria: Haemoglobin \< 7g/dl
  • Clinical/Lab Feature: Hypoglycemia Criteria: Blood glucose \< 3mmol/L
  • Clinical/Lab Feature: Abnormal temperature Criteria: Axial temperature \<36 or \>38oC
  • Clinical/Lab Feature: Very low MUAC Criteria: MUAC \<11cm

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTF75 milk feeds

Standard 'F75' (75 kcal/100 ml) 95 kcal/kg/day 12.05 mg/kg/min glucose

DIETARY_SUPPLEMENTF50 milk feeds

Reduced caloric 'F50' (50kcal/100ml) 63 kcal/kg/day 8.03mg/kg/min glucose

DIETARY_SUPPLEMENTF35 milk feeds

Reduced caloric 'F35' (35 kcal/100ml) * 47 kcal/kg/day * 5.62 mg/kg/min glucose


Locations(2)

International Centre for Diarrheal Disease Research

Dhaka, Bangladesh

Queen Elizabeth Central Hospital

Blantyre, Malawi

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06846749


Related Trials